Get 25% discount on our yearly plans! Subscribe now
| Market Cap | 1.05B |
| Total Shares Outstanding | |
| Book Value | 6.96 |
| PE Ratio | - |
| PS Ratio | 7.48 |
| PB Ratio | 3.72 |
| Forward PE Ratio | 116.28 |
| ROIC | - |
| Return on Aseets | -9.19 |
| Return on Equity | -12.43 |
| Dividend | - |
| Dividend Yield | - |
| Total Assets | 318.56M |
| Total Liability | 37.33M |
| Assets-to-Libability Ratio | 8.53 |
| Total Current Assets | 293.82M |
| Total Current Liability | 25.88M |
| Current Ratio | 11.36 |
| Quick Ratio | 10.5 |
| Debt to Equity Ratio | - |
| Net Income | -48.69M |
| EPS | -0.71 |
| EBITA | -45.00M |
| Gross Profit | 4.52M |
| Gross Profit Margin | -19.62% |
| Operating Margin | -21.46% |
| Net Profit Margin | -215.5% |
| 5 Days MA | |
| 10 Days MA | |
| 20 Days MA | |
| 50 Days MA | |
| 200 Days MA |
| 52 Weeks High | |
| 52 Weeks low | |
| All Time High |
| RSI | |
| MACD |
| Shares Float | |
| Shares Short |
| % Short | |
| % Insider | 5.056% |
| % Institutions | 91.192% |
Rxsight Inc (RXST)
RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to specific patterns of ultraviolet, which can be adjusted to improve uncorrected visual acuity; and RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.
Exchange: NASDAQ
IPO Date: 7/30/2021
Sector: Healthcare
Industry: Medical Devices
Employees: 498
Address: 100 Columbia, Aliso Viejo, CA, United States, 92656
| &ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp; | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | Totals | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | 318.56K | 310.47K | 305.50K | 183.16K | 182.55K | 181.85K | 195.26K | 202.53K | 150.16K | 155.71K | 3.22M | ||||||||||
| Current Assets | 293.82K | 286.77K | 281.22K | 168.56K | 168.41K | 167.95K | 180.44K | 187.67K | 134.56K | 139.16K | 2.92M | ||||||||||
| Cash And Short Term Investments | 237.22K | 237.12K | 233.28K | 125.35K | 127.18K | 131.88K | 147.09K | 153.94K | 105.80K | 112.83K | 2.34M | ||||||||||
| Net Receivables | 30.05K | 25.37K | 25.72K | 21.55K | 20.28K | 15.24K | 13.29K | 12.67K | 10.96K | 9.02K | 214.95K | ||||||||||
| Inventory | 22.01K | 21.67K | 19.44K | 18.70K | 17.42K | 18.92K | 17.95K | 18.07K | 14.84K | 15.34K | 248.53K | ||||||||||
| Other Current Assets | 4.54K | 2.61K | 2.77K | 2.96K | 3.52K | 1.90K | 2.11K | 2.99K | 2.96K | 1.97K | 45.44K | ||||||||||
| Non Current Assets | 24.74K | 23.70K | 24.28K | 14.61K | 14.14K | 13.90K | 14.82K | 14.87K | 15.61K | 16.54K | 300.69K | ||||||||||
| Property Plant Equipment | - | - | - | - | - | - | 13.71K | 9.80K | 10.14K | 10.62K | 124.74K | ||||||||||
| Long Term Investments | - | - | - | - | - | - | - | - | - | - | - | ||||||||||
| Non Currrent Assets Other | 1.11K | 924 | 303 | 226 | 147 | 137 | 348 | 746 | 1.53K | 1.59K | 18.57K | ||||||||||
| Liabilities | 37.33K | 33.21K | 30.29K | 19.24K | 22.19K | 20.37K | 38.07K | 57.52K | 60.26K | 59.75K | 1.45M | ||||||||||
| Current Liabilities | 25.88K | 22.64K | 19.62K | 18.33K | 20.90K | 18.94K | 16.57K | 14.88K | 17.24K | 16.37K | 264.82K | ||||||||||
| Accounts Payable | 4.54K | 4.58K | 5.09K | 5.06K | 3.86K | 4.11K | 4.00K | 3.72K | 2.60K | 4.17K | 61.09K | ||||||||||
| Short Long Term Debt | - | - | - | - | - | - | - | - | - | - | - | ||||||||||
| Other Current Liabilities | 17.25K | 18.06K | 13.05K | 10.04K | 13.19K | 12.86K | 10.59K | 9.18K | 11.32K | 10.25K | 165.44K | ||||||||||
| Non Current Liabilities | 11.45K | 10.57K | 10.67K | 908 | 1.28K | 1.43K | 21.51K | 42.65K | 43.02K | 43.38K | 1.18M | ||||||||||
| Long Term Debt | - | - | - | - | - | - | - | 42.65K | - | 43.38K | 303.95K | ||||||||||
| Other Liabilities | - | - | - | - | - | - | 76 | - | - | - | 3.90K | ||||||||||
| Stockholder Equity | 281.24K | 277.26K | 275.21K | 163.93K | 160.36K | 161.48K | 157.19K | 145.01K | 89.90K | 95.96K | 1.42M | ||||||||||
| Preferred Stock Equity | - | - | - | - | - | - | - | - | - | - | - | ||||||||||
| Liabilities And Stockholders Equity | 318.56K | 310.47K | 305.50K | 183.16K | 182.55K | 181.85K | 195.26K | 202.53K | 150.16K | 155.71K | 3.12M | ||||||||||
| Common Equity | - | - | - | - | - | - | - | 34 | 28 | 28 | 206 | ||||||||||
| Retained Earnings | - | - | - | - | - | - | - | -559.24K | -546.03K | -530.42K | -4.04M | ||||||||||
| Totals | 1.63M | 1.59M | 1.55M | 935.78K | 938.00K | 932.82K | 1.03M | 562.20K | 275.05K | 361.35K | 431.61K | 490.54K | 586.88K | 654.82K | -221.14K | 889.02K | 718.91K | - | - | 13.35M | |
| &ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp; | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | Totals | |
|---|---|---|---|---|---|---|---|---|
| Assets | 318.56K | 182.55K | 150.16K | 192.72K | 100.68K | 110.43K | 1.06M | |
| Current Assets | 293.82K | 168.41K | 134.56K | 176.29K | 81.50K | 90.20K | 944.78K | |
| Cash And Short Term Investments | 237.22K | 127.18K | 105.80K | 159.33K | 68.97K | 80.67K | 779.18K | |
| Net Receivables | 30.05K | 20.28K | 10.96K | 4.86K | 2.87K | 789 | 69.80K | |
| Inventory | 22.01K | 17.42K | 14.84K | 8.03K | 8.29K | 7.22K | 77.80K | |
| Other Current Assets | 4.54K | 3.52K | 2.96K | 8.14K | 1.37K | 1.52K | 22.06K | |
| Non Current Assets | 24.74K | 14.14K | 15.61K | 16.43K | 19.18K | 20.23K | 110.33K | |
| Property Plant Equipment | - | - | 10.14K | 11.22K | 18.61K | 19.25K | 59.21K | |
| Long Term Investments | - | - | - | - | - | - | - | |
| Non Currrent Assets Other | 1.11K | 147 | 767 | 114 | 110 | 983 | 3.23K | |
| Liabilities | 37.33K | 22.19K | 60.26K | 54.48K | 398.21K | 415.04K | 987.50K | |
| Current Liabilities | 25.88K | 20.90K | 17.24K | 11.08K | 11.60K | 8.46K | 95.15K | |
| Accounts Payable | 4.54K | 3.86K | 2.60K | 1.69K | 1.13K | 2.20K | 16.02K | |
| Short Long Term Debt | - | - | - | - | - | - | - | |
| Other Current Liabilities | 17.25K | 13.19K | 9.35K | 5.71K | 9.19K | 4.89K | 59.59K | |
| Non Current Liabilities | 11.45K | 1.28K | 43.02K | 43.40K | 386.61K | 406.59K | 892.35K | |
| Long Term Debt | - | - | - | 43.40K | - | - | 43.40K | |
| Other Liabilities | - | - | - | - | 136.89K | 189.68K | 326.57K | |
| Stockholder Equity | 281.24K | 160.36K | 89.90K | 138.24K | -297.53K | -304.61K | 67.60K | |
| Preferred Stock Equity | - | - | - | - | - | - | - | |
| Liabilities And Stockholders Equity | 318.56K | 182.55K | 150.16K | 192.72K | 100.68K | 110.43K | 1.06M | |
| Common Equity | - | - | 28 | 27 | 80.78K | 56.42K | 137.26K | |
| Retained Earnings | - | - | -546.03K | -479.28K | - | - | -1.03M | |
| Totals | 1.63M | 938.00K | 272.32K | 588.61K | 1.13M | 1.22M | 5.78M | |
| &ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp; | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | 12/31/2020 | 09/30/2020 | 06/30/2020 | 03/31/2020 | Totals | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 11.36K | 8.94K | 8.43K | 5.79K | 4.90K | 3.48K | 4.91K | 4.17K | 2.71K | 2.89K | 57.57K | |
| Cost Of Revenue | 6.57K | 5.18K | 5.56K | 4.45K | 5.71K | 2.37K | 3.53K | 3.45K | 3.18K | 2.81K | 42.80K | |
| Gross Profit | 4.79K | 3.76K | 2.87K | 1.34K | -812 | 1.12K | 1.38K | 720 | -474 | 78 | 14.77K | |
| Operating Expenses | 20.58K | 20.34K | 17.53K | 14.45K | 13.06K | 12.25K | 13.21K | 9.63K | 11.51K | 9.47K | 142.05K | |
| Selling General Administrative | 14.39K | 13.62K | 11.62K | 9.08K | 6.50K | 5.61K | 4.40K | 3.83K | 3.25K | - | 72.29K | |
| Research Development | 6.19K | 6.72K | 5.92K | 5.38K | 6.56K | 6.64K | 5.27K | 5.80K | 5.08K | 5.78K | 59.34K | |
| Other Operating Expenses | 27.15K | 25.52K | 23.09K | 18.90K | - | 14.62K | - | 13.08K | - | 12.29K | 134.64K | |
| Operating Income | -15.79K | -16.58K | -14.66K | -13.11K | -13.88K | -11.13K | -8.29K | -8.91K | -8.81K | -9.40K | -120.56K | |
| Net Interest Income | -940 | -1.01K | -1.07K | -1.07K | -811 | -681 | -477 | 60 | 143 | - | -5.86K | |
| Interest Income | 196 | 46 | 10 | 11 | 15 | 17 | 21 | 63 | 147 | - | 526 | |
| Interest Expense | 1.14K | 1.06K | 1.08K | 1.08K | 826 | 698 | 498 | 3 | 4 | 5 | 6.39K | |
| Other Income Expense Net | -940 | -1.01K | -1.07K | 435 | 1.21K | 4.34K | 35.07K | 39.58K | -4.18K | -7.10K | 66.33K | |
| Income Before Tax | -16.73K | -17.59K | -15.73K | -12.68K | -13.47K | -6.80K | 26.30K | 30.67K | -12.84K | -16.50K | -55.37K | |
| Tax Provision | - | 4 | 2 | -4 | 3 | 7 | 4 | 8 | 40 | - | 64 | |
| NetIncome | -16.73K | -17.60K | -15.73K | -12.67K | -13.48K | -6.80K | 26.30K | 30.66K | -12.88K | -16.50K | -55.44K | |
| NetIncome Applicable To Common Shares | -16.73K | -17.60K | -15.73K | -12.67K | -13.48K | -6.80K | - | 5.90K | -16.98K | -20.75K | -114.84K | |
| Ebit | -15.60K | -16.53K | -14.65K | -11.60K | -12.65K | -6.10K | - | 30.68K | -8.81K | -16.49K | -71.75K | |
| Basic EPS | - | -0.64 | -0.58 | -0.68 | -0.51 | - | -1.7 | - | - | - | -4.11 | |
| Totals | 8.90K | -2.73K | -2.56K | -2.90K | -29.78K | 12.83K | 112.13K | 169.38K | -38.90K | -53.42K | 172.94K | |
| &ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp; | 12/31/2021 | 12/31/2020 | 12/31/2019 | Totals | |
|---|---|---|---|---|---|
| Revenue | 22.59K | 14.68K | 2.24K | 39.51K | |
| Cost Of Revenue | 18.08K | 12.97K | 4.06K | 35.11K | |
| Gross Profit | 4.52K | 1.71K | -1.82K | 4.40K | |
| Operating Expenses | 57.30K | 37.11K | 44.77K | 139.19K | |
| Selling General Administrative | 32.80K | 15.18K | 15.20K | 63.18K | |
| Research Development | 24.50K | 21.93K | 29.57K | 76.00K | |
| Other Operating Expenses | 75.38K | 50.08K | 48.83K | 174.29K | |
| Operating Income | -52.79K | -35.41K | -46.07K | -134.27K | |
| Net Interest Income | -3.63K | 33 | 2.28K | -1.31K | |
| Interest Income | 54 | 543 | 2.31K | 2.90K | |
| Interest Expense | 3.68K | 510 | 26 | 4.22K | |
| Other Income Expense Net | 4.11K | 63.04K | 172.31K | 239.47K | |
| Income Before Tax | -48.68K | 27.63K | 126.24K | 105.20K | |
| Tax Provision | 8 | 57 | 24 | 89 | |
| NetIncome | -48.69K | 27.57K | 126.22K | 105.11K | |
| NetIncome Applicable To Common Shares | -48.69K | 3.37K | 26.13K | -19.20K | |
| Ebit | -45.00K | 28.14K | 126.27K | 109.41K | |
| Basic EPS | -1.77 | -1.7 | - | -3.4699999999999998 | |
| Totals | -4.45K | 269.15K | 678.60K | 943.30K | |
| &ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp; | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | Totals | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash From Operating Activities | -4.26K | 650 | -4.11K | -9.31K | -9.89K | -7.98K | -7.55K | -17.76K | -13.85K | -15.19K | -198.97K | |||||||||||
| Net Income | -5.94K | -6.34K | -6.08K | -9.10K | -9.18K | -12.41K | -13.80K | -13.21K | -15.61K | -16.82K | -163.93K | |||||||||||
| Depreciation | 523 | 1.14K | 820 | 1.14K | 1.08K | 1.13K | 1.03K | 999 | 961 | 980 | 19.89K | |||||||||||
| Extraordinary Items | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
| Change Receivables | - | - | - | - | - | - | - | -1.71K | -1.94K | -2.14K | -7.81K | |||||||||||
| Change To Inventory | -408 | -2.40K | -799 | -1.39K | 1.35K | -977 | 117 | -3.24K | 203 | -4.05K | -18.71K | |||||||||||
| Change To Liabilities | - | - | - | - | - | - | - | -2.33K | 730 | 3.35K | 1.61K | |||||||||||
| Change To Net Income | - | - | - | - | - | - | - | 3.31K | 3.26K | 3.22K | -7.94K | |||||||||||
| ChangeToOperatingActivities | - | - | - | - | - | - | - | 2.81K | - | 2.88K | 4.98K | |||||||||||
| Cash flows From Investing Activities | - | - | - | - | - | - | - | -48.37K | 10.40K | 560 | -60.22K | |||||||||||
| Capital Expenditures | -847 | -1.10K | -1.52K | -1.97K | -1.59K | -653 | -1.82K | -747 | -362 | -580 | -17.13K | |||||||||||
| Other Cashflows From Investing Activities | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
| Cash From Financing Activities | 2.98K | 878 | 111.55K | 7.99K | 5.15K | -8.23K | 891 | 65.31K | 6.31K | -455 | 355.42K | |||||||||||
| Net Borrowings | - | - | - | - | - | - | - | -20.04K | -1 | -2 | -5.26K | |||||||||||
| Sale Purchase Of Stock | - | 2.13K | 1 | - | -2 | -1.08K | - | -337 | -1.48K | -150 | 124 | |||||||||||
| Dividends Paid | - | - | - | - | - | 1.08K | - | 337 | - | - | 1.42K | |||||||||||
| Other Cashflows From Financing Activities | - | 889 | -376 | -2.13K | -610 | 40 | 17.64K | 868 | 1.49K | -578 | 142.89K | |||||||||||
| Cash And Cash Equivalents Changes | - | - | - | - | - | - | - | -824 | 2.86K | -15.08K | -13.39K | |||||||||||
| Totals | -7.95K | -4.15K | 99.49K | -14.77K | -13.68K | -29.09K | -3.49K | -34.95K | -7.03K | -44.05K | -16.01K | -17.13K | -52.77K | 133.38K | 15.88K | 10.07K | 43.49K | -7.51K | -15.76K | -985 | 32.99K | |
| &ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp; | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | Totals | |
|---|---|---|---|---|---|---|---|---|
| Cash From Operating Activities | -16.95K | -41.59K | -58.85K | -44.71K | -35.20K | -40.62K | -237.92K | |
| Net Income | -27.45K | -48.61K | -66.76K | -48.69K | 27.57K | 126.22K | -37.71K | |
| Depreciation | 3.62K | 4.24K | 4.02K | 3.99K | 4.01K | 3.93K | 23.82K | |
| Extraordinary Items | - | - | - | - | - | - | - | |
| Change Receivables | - | - | -6.09K | -2.00K | - | - | -8.09K | |
| Change To Inventory | -4.99K | -2.75K | -7.55K | -2.11K | -1.31K | -5.47K | -24.19K | |
| Change To Liabilities | - | - | 5.45K | 4.24K | -954 | 1.13K | 9.87K | |
| Change To Net Income | - | - | 12.15K | 7.22K | -59.03K | -166.80K | -206.45K | |
| ChangeToOperatingActivities | - | - | 5.60K | 874 | -3.51K | 1.16K | 4.12K | |
| Cash flows From Investing Activities | - | - | 39.95K | -81.91K | 15.59K | -5.87K | -32.24K | |
| Capital Expenditures | -5.44K | -4.81K | -2.39K | -1.94K | -2.54K | -4.09K | -21.21K | |
| Other Cashflows From Investing Activities | - | - | - | - | - | - | - | |
| Cash From Financing Activities | 123.32K | 61.52K | 6.33K | 137.34K | 25.24K | 1.33K | 355.08K | |
| Net Borrowings | - | - | -145 | 14.87K | 24.86K | -185 | 39.40K | |
| Sale Purchase Of Stock | - | -1.42K | -643 | 121.93K | - | - | 119.86K | |
| Dividends Paid | - | - | 643 | - | - | - | 643 | |
| Other Cashflows From Financing Activities | - | -4.28K | -1.38K | 1.23K | 379 | 1.51K | -2.53K | |
| Cash And Cash Equivalents Changes | - | - | -12.57K | 10.73K | - | - | -1.84K | |
| Totals | 72.11K | -37.70K | -82.23K | 121.07K | -4.89K | -87.75K | -19.39K | |
